От началото на април е спряна продажбата на 17 лекарства

1

KANJINTI 150 mg powder for concentrate for solution for infusion x 1 vial

Trastuzumab

2

MVASI 25 mg/ml concentrate for solution for infusion 16 ml x 1 vial

Bevacizumab

3

MVASI 25 mg/ml concentrate for solution for infusion 4 ml x 1 vial

Bevacizumab

4

Upsarin C 330 mg/200 mg effervescent tablets x 10

Acetylsalicylic acid/Ascorbic acid

5

Thioctacid 600 T 600 mg/24 ml solution for injection x 5 amp.

Thioctic acid

6

Atofab 10 mg hard capsules x 30

Atomoxetine

7

Nimenrix powder and solvent for solution for injection in pre-filled syringe x 1 vial + 1 pre-filled syringe + 2 needles Meningococcal groups A, C, W-135 and Y conjugate vaccine

Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated

8

Salmeterol and fluticasone Cipla 25 micrograms/250 micrograms/dose pressurised inhalation, susp. x 1 

Salmeterol/Fluticasone

9

Depakine 400 mg powder and solvent for solution for injection x 1

Valproic acid

10

Salofalk 500 mg gastro-resistant tablets x 100

Mesalazine

11

Infaresp 0,5 mg/2 ml nebuliser suspension x 20

Budesonide

12

Donecept 5 mg film-coated tablets x 30

Donepezil

13

Ziextenzo 6 mg solution for injection in pre-filled syringe 0,6 ml (10 mg/ml) x 1

Pegfilgrastim

14

Degan 10 mg tablets x 30

Metoclopramide

15

Rixathon 500 mg concentrate for solution for infusion 50 ml (10 mg/ml) x 1 vial

Rituximab

16

AirBuFo Forspiro 160 micrograms+4,5 micrograms/dose inhalation powder, pre-dispensed 60 doses x 2

Budesonide/Formoterol

17

GlucaGen HypoKit 1 mg powder and solvent for solution for injection x 1 vial

Glucagon